Advanced in Multiple Sclerosis (MS)

Klara Z. Bakhtiyarova

Ufa, BA, RU 
Advanced in Multiple Sclerosis (MS)
Ufa, BA, RU 
OverviewLocationsClinical Research

Overview

Klara Bakhtiyarova practices in Ufa, Russian Federation. Ms. Bakhtiyarova is rated as an Advanced expert by MediFind in the treatment of Multiple Sclerosis (MS). Her top areas of expertise are Multiple Sclerosis (MS), Alpers-Huttenlocher Syndrome, Relapsing Multiple Sclerosis (RMS), and Tumefactive Multiple Sclerosis.

Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles and participated in 1 clinical trial in the study of Multiple Sclerosis (MS).

Gender
Female

Locations

Ufa, BA, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.
Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drug: Prospecta
Study Phase: Phase 3
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

17 Total Publications

Search for informative predictors of the development and progression of multiple sclerosis
Search for informative predictors of the development and progression of multiple sclerosis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bakhtiyarova's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile